{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:51:56Z","timestamp":1789692716210,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12957-015-0638-y","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T20:25:05Z","timestamp":1438806305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Manchester guidelines for contralateral risk-reducing mastectomy"],"prefix":"10.1186","volume":"13","author":[{"given":"Narendra Nath","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G L","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"issue":"33","key":"638_CR1","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203\u20139.","journal-title":"J Clin Oncol"},{"issue":"12","key":"638_CR2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","volume":"29","author":"HB Nichols","year":"2011","unstructured":"Nichols HB, Berrington de Gonz\u00e1lez A, Lacey Jr JV, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;29(12):1564\u20139. doi: 10.1200\/JCO.2010.32.7395 .","journal-title":"J Clin Oncol"},{"key":"638_CR3","doi-asserted-by":"crossref","unstructured":"Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, et al. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ. 2014;348:g226. doi: 10.1136\/bmj.g226 .","DOI":"10.1136\/bmj.g226"},{"key":"638_CR4","doi-asserted-by":"crossref","unstructured":"Evans DG, Ingham SL, Baildam A, Ross GL, Lalloo F, Buchan I, et al. Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer. Breast Cancer Res Treat. 2013;140(1):135\u201342.","DOI":"10.1007\/s10549-013-2583-1"},{"key":"638_CR5","volume":"11","author":"L Lostumbo","year":"2010","unstructured":"Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;11, CD002748.","journal-title":"Cochrane Database Syst Rev"},{"key":"638_CR6","doi-asserted-by":"crossref","first-page":"f3829","DOI":"10.1136\/bmj.f3829","volume":"346","author":"DG Evans","year":"2013","unstructured":"Evans DG, Graham J, O'Connell S, Arnold S, Fitzsimmons D. Familial breast cancer: summary of updated NICE guidance. BMJ. 2013;346:f3829. doi: 10.1136\/bmj.f3829 .","journal-title":"BMJ"},{"issue":"7","key":"638_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/ejso.2000.0986","volume":"26","author":"F Lalloo","year":"2000","unstructured":"Lalloo F, Baildam A, Brain A, Hopwood P, Evans DG, Howell A. A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer. Eur J Surg Oncol. 2000;26(7):711\u20133.","journal-title":"Eur J Surg Oncol"},{"key":"638_CR8","first-page":"901046","volume":"2015","author":"NN Basu","year":"2015","unstructured":"Basu NN, Barr L, Ross GL, Evans DG. Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies. Int J Surg Oncol. 2015;2015:901046. Epub 2015 Jan 27. Review.","journal-title":"Int J Surg Oncol"},{"key":"638_CR9","doi-asserted-by":"crossref","unstructured":"Basu NN, Littlechild S, Evans DG, Ross GL, Barr L. Contralateral risk reducing mastectomy\u2014a national survey of surgeons\u2019 practices and perceptions. Eur J Surg Oncol. 2013;39(11):S64. doi: 10.1016\/j.ejso.2013.07.190 .","DOI":"10.1016\/j.ejso.2013.07.190"},{"key":"638_CR10","doi-asserted-by":"crossref","unstructured":"Basu NN, Short J, Evans DG, Barr L. Contralateral risk-reducing mastectomy\u2014the Manchester experience. Eur J Surg Oncol. 2014;40(5):618. doi: 10.1016\/j.ejso.2014.02.031 .","DOI":"10.1016\/j.ejso.2014.02.031"},{"issue":"2","key":"638_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.breast.2012.06.005","volume":"22","author":"H Beesley","year":"2013","unstructured":"Beesley H, Holcombe C, Brown SL, Salmon P. Risk, worry and cosmesis in decision-making for contralateral risk-reducing mastectomy: analysis of 60 consecutive cases in a specialist breast unit. Breast. 2013;22(2):179\u201384. doi: 10.1016\/j.breast.2012.06.005 .","journal-title":"Breast"},{"key":"638_CR12","doi-asserted-by":"crossref","unstructured":"Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, et al. Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg. 2011;201(5):615\u20138. doi: 10.1016\/j.amjsurg.2011.01.018 .","DOI":"10.1016\/j.amjsurg.2011.01.018"},{"issue":"17","key":"638_CR13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/93.17.1297","volume":"93","author":"M Stefanek","year":"2001","unstructured":"Stefanek M, Hartmann L, Nelson W. Risk-reduction mastectomy: clinical issues and research needs. JNCI. 2001;93(17):1297\u2013306.","journal-title":"JNCI"},{"key":"638_CR14","doi-asserted-by":"crossref","unstructured":"Meiser B, Butow P, Friedlander M, Schnieden V, Gattas M, Kirk J, et al. Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol. 2000;18(11):2250\u20137.","DOI":"10.1200\/JCO.2000.18.11.2250"},{"issue":"8","key":"638_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.2013.101055","volume":"310","author":"SJ Katz","year":"2013","unstructured":"Katz SJ, Morrow M. Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. JAMA. 2013;310(8):793\u20134.","journal-title":"JAMA"},{"key":"638_CR16","doi-asserted-by":"crossref","unstructured":"Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, et al. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res. 2014;16(5):442. doi: 10.1186\/s13058-014-0442-6 .","DOI":"10.1186\/s13058-014-0442-6"},{"key":"638_CR17","doi-asserted-by":"crossref","unstructured":"Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013;159(6):373\u201381. doi: 10.7326\/0003-4819-159-6-201309170-00003 .","DOI":"10.7326\/0003-4819-159-6-201309170-00003"},{"key":"638_CR18","doi-asserted-by":"crossref","unstructured":"Evans DG, Moran A, Hartley R, Dawson J, Bulman B, Knox F, et al. Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1\/BRCA2\/TP53 status. Br J Cancer. 2010;102(7):1091\u20138. doi: 10.1038\/sj.bjc.6605606 . Epub 2010 Mar 16.","DOI":"10.1038\/sj.bjc.6605606"},{"issue":"5","key":"638_CR19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.amjsurg.2013.08.002","volume":"206","author":"IM Lizarraga","year":"2013","unstructured":"Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CEH. Review of risk factors for the development of contralateral breast cancer. Am J Surg. 2013;206(5):704\u20138. doi: 10.1016\/j.amjsurg.2013.08.002 .","journal-title":"Am J Surg"},{"key":"638_CR20","unstructured":"National Life Tables, United Kingdom (2010-12) http:\/\/www.ons.gov.uk\/ons\/rel\/lifetables\/national-life-tables\/2010---2012\/stb-uk-2010-2012.html#tab-Life-Expenctancy-at-Birth"},{"key":"638_CR21","doi-asserted-by":"crossref","unstructured":"Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362\u20137.","DOI":"10.1200\/JCO.2008.20.1681"},{"key":"638_CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-60761-759-4_14","volume":"653","author":"GR Evans","year":"2010","unstructured":"Evans GR, Lalloo F. Development of a scoring system to screen for BRCA1\/2 mutations. Methods Mol Biol. 2010;653:237\u201347. doi: 10.1007\/978-1-60761-759-4_14 .","journal-title":"Methods Mol Biol"},{"key":"638_CR23","unstructured":"Leff DR, Ho C, Thomas H, Daniels R, Side L, Lambert F et al. A multi-disciplinary team approach minimises prophylactic mastectomy rates. Eur J Surg Oncol 2015. doi: 10\/1016\/j.ejso.2015.02.2017"},{"key":"638_CR24","doi-asserted-by":"crossref","first-page":"831605","DOI":"10.4061\/2011\/831605","volume":"2011","author":"V Patkar","year":"2011","unstructured":"Patkar V, Acosta D, Davidson T, Jones A, Fox J, Keshtgar M. Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer. 2011;2011:831605. doi: 10.461\/2011\/831605 . Epub 2011 jul 17.","journal-title":"Int J Breast Cancer"},{"key":"638_CR25","doi-asserted-by":"crossref","unstructured":"Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkj\u00e6r L, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women\u2019s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013;31(4):433\u20139. doi: 10.1200\/JCO.2012.43.2013 . Epub 2012 Dec 26.","DOI":"10.1200\/JCO.2012.43.2013"},{"key":"638_CR26","doi-asserted-by":"crossref","unstructured":"Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22(12):2328\u201335.","DOI":"10.1200\/JCO.2004.04.033"},{"issue":"3","key":"638_CR27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10549-012-2183-5","volume":"135","author":"BS Saltzman","year":"2012","unstructured":"Saltzman BS, Malone KE, McDougall JA, Daling JR, Li C. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer. Breast Cancer Res Treat. 2012;135(3):849\u201355. doi: 10.1007\/s10549-012-2183-5 . Epub 2012 Aug 19.","journal-title":"Breast Cancer Res Treat"},{"key":"638_CR28","doi-asserted-by":"crossref","unstructured":"Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, et al. ATAC\/LATTE investigators. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010;11(12):1135\u201341.","DOI":"10.1016\/S1470-2045(10)70257-6"},{"key":"638_CR29","doi-asserted-by":"crossref","unstructured":"Basu NN, O\u2019Driscoll M, Ahmed M, Ingham S, Howell A, Lalloo F, et al. Contralateral breast cancer in high-risk patients: identification of risk factors to guide recommendations for contralateral prophylactic mastectomy\u2014a 30-year experience. 2013, 39(5): 520. doi: http:\/\/dx.doi.org\/10.1016\/j.ejso.2013.01.024","DOI":"10.1016\/j.ejso.2013.01.024"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-015-0638-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-015-0638-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-015-0638-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T23:03:19Z","timestamp":1567033399000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjso.com\/content\/13\/1\/237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["638"],"URL":"https:\/\/doi.org\/10.1186\/s12957-015-0638-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]},"article-number":"237"}}